# FDA Inspection 1225161 - Taiho Pharmaceutical Co., Ltd. - October 13, 2023

Source: https://www.keypedia.com/records/fda_inspections/taiho-pharmaceutical-co-ltd/8181acbf-fefa-40cf-95a7-cf61268694a5
Source feed: FDA_Inspections

> FDA Inspection 1225161 for Taiho Pharmaceutical Co., Ltd. on October 13, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1225161
- Company Name: Taiho Pharmaceutical Co., Ltd.
- Inspection Date: 2023-10-13
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 929395 - 2015-05-15](https://www.keypedia.com/records/fda_inspections/taiho-pharmaceutical-co-ltd/076a1b2f-5cf7-4992-9650-ed15ae51f21a)

Company: https://www.keypedia.com/companies/taiho-pharmaceutical-co-ltd/7d4d20d3-f100-499f-9176-e379a48dcb7b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c